Last SFr.98.65 CHF
Change Today +0.40 / 0.41%
Volume 16.6K
TECN On Other Exchanges
Symbol
Exchange
OTC US
Munich
SIX Swiss Ex
OTC US
As of 11:43 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

tecan group ag-reg (TECN) Snapshot

Open
SFr.98.90
Previous Close
SFr.98.25
Day High
SFr.99.25
Day Low
SFr.98.15
52 Week High
05/2/14 - SFr.111.10
52 Week Low
07/26/13 - SFr.84.70
Market Cap
1.1B
Average Volume 10 Days
10.8K
EPS TTM
SFr.4.17
Shares Outstanding
11.4M
EX-Date
04/16/14
P/E TM
23.7x
Dividend
SFr.1.50
Dividend Yield
1.52%
Current Stock Chart for TECAN GROUP AG-REG (TECN)

Related News

No related news articles were found.

tecan group ag-reg (TECN) Related Businessweek News

No Related Businessweek News Found

tecan group ag-reg (TECN) Details

Tecan Group Ltd. provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, forensic, and diagnostic laboratories. It operates in two segments, Life Sciences Business and Partnering Business. The company specializes in the development, production, and distribution of automated workflow solutions for laboratories in the life sciences sector, as well as developing and manufacturing original equipment manufacturer instruments and components. Its automation solutions include instruments, software packages, numerous configurable modules, and special application expertise, as well as regulatory and quality consulting, service, and consumables. The company offers liquid handling platforms, which are used to pipette fluids with optimum precision and automate laborious and repetitive manual procedures; a range of bioanalytical instruments, such as microplate readers and washers that allow reactions to be monitored or analyses to be measured; and detection instruments. It also provides laboratory automation components, such as precision pumps, valves, and robotic arms, as well as develops software for laboratory instrument manufacturers under the Cavro brand. In addition, the company offers consumables, such as pipette tips, a laboratory automation solution. Tecan Group distributes its products through its own market organization and distributors in approximately 52 countries worldwide. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

1,184 Employees
Last Reported Date: 03/24/14
Founded in 1980

tecan group ag-reg (TECN) Top Compensated Officers

Chief Executive Officer and Member of Managem...
Total Annual Compensation: SFr.1.0M
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: SFr.455.0K
Compensation as of Fiscal Year 2013.

tecan group ag-reg (TECN) Key Developments

Tecan Group Ltd. Unveils New Fluent(TM) Laboratory Automation Solutions

The Tecan Group announced the launch of the Fluent(TM) laboratory automation family as the latest addition to its extensive liquid handling portfolio. Fluent is a unique automation concept built around the application-specific needs of laboratories, delivering more capacity and increased speed. With an initial focus on the complete automation of cell-based and biochemical assay workflows, the new systems bring together all the modules and devices required for these assays in a simple, productive and easy-to-use platform. Fluent reflects the increasingly application-focused nature of the life sciences market, as scientists look to partner with equipment manufacturers that can provide this type of high quality and user-friendly technical solution, backed by knowledgeable and responsive application support. The Fluent solution for cell-based assays is designed to take the complexity out of cell biology research, simplify day-to-day tasks and increase both throughput and reliability. High definition liquid handling ensures precision and accuracy over a wide dynamic range, from sub-microliter to milliliter volumes. Patented Adaptive Signal Technology(TM) precisely detects even small volumes enabling accurate monitoring of liquid, allowing for the use of smaller reagent and sample volumes for significant cost savings. The patented Dynamic Deck(TM) uses a modular, multilevel design to offer exceptional deck capacity, allowing flexible integration of all the complementary devices required for cell-based research - including incubators, washers and readers - into a single, fully automated system. Liquid handling and labware logistics have never been easier, due to the instrument's three, task-specific arms which operate simultaneously to ensure timely completion of assays, minimizing the time cells spend outside of the incubator. Perfect coordination of the robotic arms is achieved by the platform's Path Finder(TM) move optimization technology, which continuously adapts to the changing topography of the workdeck, avoiding the need for laborious programming of individual arm movements, helping to accelerate both set-up and routine system use. The platform's intuitive FluentControl(TM) software and built-in touchscreen interface simplify day-to-day activities by guiding scientists through routine set-up and operation of the system for consistent, reproducible operation. Fluent is launched together with specific application notes that were developed together with partners to generate real scientific data and provide a proof of concept for a selection of commonly-used cell-based assays.

The Tecan Group Announces Management Changes

The Tecan Group announced that Ulrich Kanter has been appointed as a member of the Management Board. As Head of the Development & Operations division, effective July 14, 2014, he will assume responsibility for development activities, production, supply chain management and materials purchasing at Tecan. Dr. Martin Brusdeilins, who has headed this division since November 2011, will retire at the end of September 2014 and step down from the Management Board. Until this time, he will continue to act as Chief Scientific Officer, a position that he holds in addition to being Head of the division. Tecan has initiated the search for a successor to take on this role. Ulrich Kanter worked in various areas and held diverse positions with increasing management responsibility at Roche Diagnostics from 2000. He was General Manager and Head of Research & Development in Graz, Austria, from 2007, with responsibility for the entire value chain of blood gas and electrolyte analysis systems for this Roche division. Prior to this, he managed the development of these systems as Senior Vice President Research & Development, and as Site Manager was responsible for management of the supply chain as well as all administrative matters at the Graz site.

Tecan Group AG Declares Dividend Payment, Payable on April 23, 2014

Tecan Group AG announced that at the annual general meeting held on April 14, 2014, the company shareholders approved the dividend payment of CHF 1.50 per share. The company approved an unchanged dividend versus the previous year of CHF 1.50 per registered share. The payout will take place on April 23, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TECN:SW SFr.98.65 CHF +0.40

TECN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TECN.
View Industry Companies
 

Industry Analysis

TECN

Industry Average

Valuation TECN Industry Range
Price/Earnings 23.7x
Price/Sales 2.8x
Price/Book 3.2x
Price/Cash Flow 24.4x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TECAN GROUP AG-REG, please visit www.tecan.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.